Quick Answer
Atara Biotherapeutics, Inc. reported Total Assets of $20.23 million for fiscal year 2025.
Atara Biotherapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $20.23M | -81.5% |
| 2024 | $109.10M | -34.1% |
| 2023 | $165.50M | -56.0% |
| 2022 | $376.42M | -19.6% |
| 2021 | $468.13M | -20.4% |
| 2020 | $588.12M | +71.5% |
| 2019 | $342.94M | -12.5% |
| 2018 | $391.84M | +79.9% |
| 2017 | $217.78M | -17.5% |
| 2016 | $263.91M | -18.8% |
| 2015 | $324.98M | +206.2% |
| 2014 | $106.12M | +104.8% |
| 2013 | $51.83M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $30.17M | -78.9% | -18.3% |
| June 30, 2025 | $36.90M | -68.5% | -40.5% |
| March 31, 2025 | $62.04M | -62.5% | -43.1% |
| December 31, 2024 | $109.10M | -34.1% | -23.6% |
| September 30, 2024 | $142.71M | -24.4% | +21.7% |
| June 30, 2024 | $117.28M | -52.4% | -29.0% |
| March 31, 2024 | $165.27M | -45.3% | -0.1% |
| December 31, 2023 | $165.50M | -56.0% | -12.3% |
- Atara Biotherapeutics, Inc. showed a decrease of -81.5% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Atara Biotherapeutics, Inc.’s total assets has declined by 61.0% (from $51.83 million to $20.23 million).
- The most recent figure is from Atara Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: